Skip to main content

Table 1 Patient characteristics

From: The value of 18F-PSMA-1007 PET/CT in identifying non-metastatic high-risk prostate cancer

Patients (n)

101

Age median (range)

69 years (43–87)

PSA median (range)

11.113 ng/ml (0.970–178.200)

IR(n)

49

HR(n)

52

GS

 

 GS 6

4

 GS 7a

30

 GS 7b

37

 GS 8

9

 GS 9

21

Clinical T-stage

 

 T1c

41

 T2a

9

 T2b

7

 T2c

39

 T3a

2

 T3b

3

  1. N, number; IR, intermediate-risk group; HR, high-risk group; GS, Gleason score; GS 7a corresponds to GS 3 + 4; GS 7b corresponds to GS 4 + 3